Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 25;12(8):2221.
doi: 10.3390/nu12082221.

B12 as a Treatment for Peripheral Neuropathic Pain: A Systematic Review

Thomas Julian  1   2 , Rubiya Syeed  1 , Nicholas Glascow  3 , Efthalia Angelopoulou  4 , Panagiotis Zis  5
Affiliations

B12 as a Treatment for Peripheral Neuropathic Pain: A Systematic Review

Thomas Julian et al. Nutrients. .

Abstract

Neuropathic pain describes a range of unpleasant sensations caused by a lesion or disease of the somatosensory nervous system. The sensations caused by neuropathic pain are debilitating and improved treatment regimens are sought in order to improve the quality of life of patients. One proposed treatment for neuropathic pain is vitamin B12, which is thought to alleviate pain by a number of mechanisms including promoting myelination, increasing nerve regeneration and decreasing ectopic nerve firing. In this paper, the evidence for B12 as a drug treatment for neuropathic pain is reviewed. Twenty four published articles were eligible for inclusion in this systematic review in which a range of treatment regimens were evaluated including both B12 monotherapy and B12 in combination with other vitamins or conventional treatments, such as gabapentinoids. Overall, this systematic review demonstrates that there is currently some evidence for the therapeutic effect of B12 in the treatment of post-herpetic neuralgia (level II evidence) and the treatment of painful peripheral neuropathy (level III evidence).

Keywords: B12; cobalamin; methylcobalamin; neuropathic; neuropathy; pain.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
A PRISMA chart illustrating the reasons for exclusion.
See this image and copyright information in PMC

References

    1. The IASP Subcommittee on Taxonomy Pain terms a list with definitions and notes on usage. Recommended by the IASP subcommittee on taxonomy. [(accessed on 19 June 2020)];Pain. 1979 6:249. Available online: https://pubmed.ncbi.nlm.nih.gov/460932/ - PubMed
    1. Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. [(accessed on 19 June 2020)];Rev. Neurol. 2018 175:16–25. doi: 10.1016/j.neurol.2018.09.016. Available online: http://www.ncbi.nlm.nih.gov/pubmed/30385075. - DOI - PubMed
    1. Brozou V., Vadalouca A., Zis P. Pain in platin-induced neuropathies: A systematic review and meta-analysis. [(accessed on 19 June 2020)];Pain Ther. 2018 7:105–119. Available online: http://link.springer.com/10.1007/s40122-017-0092-3. - DOI - PMC - PubMed
    1. Julian T., Glascow N., Syeed R., Zis P. Alcohol-related peripheral neuropathy: A systematic review and meta-analysis. J. Neurol. 2019;266:2907–2919. doi: 10.1007/s00415-018-9123-1. - DOI - PMC - PubMed
    1. Zis P., Varrassi G. Painful peripheral neuropathy and cancer. [(accessed on 19 June 2020)];Pain Ther. 2017 6:115–116. doi: 10.1007/s40122-017-0077-2. Available online: http://www.ncbi.nlm.nih.gov/pubmed/28669084. - DOI - PMC - PubMed

Publication types

MeSH terms